🟢 HIMS is trading 4.1% up today as investors reassess Amazon Pharmacy competition

HIMS is trading at $26.71, up 4.1% as investors reassess the competitive impact of Amazon Pharmacy's GLP-1 expansion.

• The stock is rebounding sharply from a 4.6% drop to $25.65 in the previous session, which was triggered by Amazon's move to offer same-day delivery for weight-loss medications.
• Today's recovery suggests value-finding after the sharp selloff, with investors weighing the actual long-term threat to Hims & Hers' market share.
• Broader market strength is providing additional support for the rebound, with the NASDAQ rising 1.36% and the S&P 500 gaining 0.79%.